维拉德美制药 MANE
$138.78 +$10.18 (+7.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $139.33 +0.40%
开盘$130.93
昨收$128.60
当日区间$130.00 – $139.89
成交量503.3K
市值$5.80B
市盈率（TTM）–
股息率–
MANE 相关新闻
匹配 Veradermics 或代码 MANE 的头条新闻，按最新排序。
- Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $160
- Veradermics(MANE.US) Officer Sells US$7.28 Million in Common Stock
- Veradermics(MANE.US) Officer Sells US$4.69 Million in Common Stock
- Needham Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $164
- Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX) 正面
- LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $170
- Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $182 正面
- Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $182
- B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
- Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $160 正面
- Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)
- LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $170 正面
- Needham Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $164 正面
- B. Riley Securities Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $170
- Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135
暂无评论——快来第一个聊聊 MANE。
登录后参与讨论。